8h
GlobalData on MSNBioCity and MSD to evaluate cancer treatment combination in Phase I/II trialBioCity Biopharmaceuticals and MSD have signed a clinical trial partnership agreement to assess BC3195 in conjunction with ...
Therefore, we’re here with a list of the 10 most undervalued S&P 500 stocks to buy now to help you diversify your portfolio.
Value investing has long been a preferred strategy among investors, largely influenced by Warren Buffett, who continues to ...
Opinion
4hOpinion
Zacks Investment Research on MSNTop Analyst Reports for AbbVie, Lockheed Martin & DellThe Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 12 major stocks, including AbbVie Inc. (ABBV), Lockheed Martin ...
A very bullish analyst move was the news generally responsible for Summit Therapeutics' (NASDAQ: SMMT) healthy mid-week stock ...
Hope for aggressive breast cancer. Survivors and doctors discuss breakthroughs, fears, and the need for inclusive research.
Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.
The BRAVE-AA-PEDS trial found that once-daily baricitinib significantly improved hair regrowth on the scalp, eyebrows, and ...
All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results